Literature DB >> 3350843

Biosynthesis of pyrimidine nucleotides and level of cytochrome P-450 in rat liver and kidney after clofibrate administration (an in vivo study).

J Seifert1, Z Machková.   

Abstract

Like other lipid-soluble xenobiotics, clofibrate (ethyl-2-(4-chlorophenoxy)-2-methylpropanoate) increased the level of microsomal cytochrome P-450 in liver and decreased the utilization of 14C-orotic acid for the synthesis of hepatic cytidine nucleotides. This phenomenon was associated with the increased (a) uptake of 14C-cytidine, (b) total content of cytidine components of the acid-soluble extract and (c) utilization of this nucleoside for the synthesis of RNA. No changes were observed in uridine components. Clofibrate also increased the level of cytochrome P-450 in kidney microsomes; the degree of induction was almost the same as in the liver. The variations of renal pyrimidine metabolism after administration of the drug were analogous to those observed in the liver.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350843     DOI: 10.1007/bf00390486

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Microsomal inducers of drug-metabolizing enzymes suppress cytidine nucleotide biosynthesis in rat liver.

Authors:  J Seifert; J Vácha
Journal:  Arch Biochem Biophys       Date:  1975-03       Impact factor: 4.013

3.  Effect of nafenopin and clofibrate on uptake and utilization of labeled thymidine for DNA synthesis in rat liver and kidney.

Authors:  J Seifert; H Mostecká
Journal:  Carcinogenesis       Date:  1988-01       Impact factor: 4.944

4.  Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity.

Authors:  C L Litterst; E G Mimnaugh; T E Gram
Journal:  Biochem Pharmacol       Date:  1977-04-15       Impact factor: 5.858

5.  Effect of clofibrate on DNA synthesis in rat liver and kidney.

Authors:  J Seifert; H Mostecká
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

6.  Microbody (peroxisome) proliferation in mouse kidney induced by methyl clofenapate.

Authors:  J K Reddy; T P Krishnakantha; M S Rao
Journal:  Virchows Arch B Cell Pathol       Date:  1975

Review 7.  Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

Authors:  J K Reddy; N D Lalwai
Journal:  Crit Rev Toxicol       Date:  1983       Impact factor: 5.635

8.  Induction of rabbit renal mixed-function oxidases by phenobarbital: cell specific ultrastructural changes in the proximal tubule.

Authors:  G F Rush; K Maita; S D Sleight; J B Hook
Journal:  Proc Soc Exp Biol Med       Date:  1983-04

9.  Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).

Authors:  G G Gibson; T C Orton; P P Tamburini
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

10.  Cytochrome P-450 monooxygenase system in the rabbit kidney: its intranephron localization and its induction.

Authors:  H Endou
Journal:  Jpn J Pharmacol       Date:  1983-04
View more
  1 in total

1.  Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.

Authors:  E F Solomayer; I J Diel; D Wallwiener; S Bode; G Meyberg; M Sillem; C Gollan; M D Kramer; U Krainick; G Bastert
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.